These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1122293)

  • 1. Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):370-84. PubMed ID: 1122293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):360-9. PubMed ID: 47244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and antiheparin properties of human platelet factor 4 (PF4).
    Nath N; Lowery CT; Niewiarowski S
    Blood; 1975 Apr; 45(4):537-50. PubMed ID: 803847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.
    Joist JH; Niewiarowski S; Nath N; Mustard JF
    J Lab Clin Med; 1976 Apr; 87(4):659-69. PubMed ID: 131845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of membrane proteins mediating the interaction of human platelets.
    Phillips DR; Jennings LK; Edwards HH
    J Cell Biol; 1980 Jul; 86(1):77-86. PubMed ID: 6893455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of human platelet proteoglycan.
    Okayama M; Oguri K; Fujiwara Y; Nakanishi H; Yonekura H; Kondo T; Ui N
    Biochem J; 1986 Jan; 233(1):73-81. PubMed ID: 3954736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen-mediated platelet aggregation. Effects of collagen modification involving the protein and carbohydrate moieties.
    Puett D; Wasserman BK; Ford JD; Cunningham LW
    J Clin Invest; 1973 Oct; 52(10):2495-506. PubMed ID: 4354000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4.
    Levine SP; Wohl H
    J Biol Chem; 1976 Jan; 251(2):324-8. PubMed ID: 812871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL; Katz AJ; Feinstein MB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of human and bovine platelet factor 4.
    Wu VY; Walz DA; McCoy LE
    Prep Biochem; 1977; 7(6):479-93. PubMed ID: 343096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition.
    Heldin CH; Westermark B; Wasteson A
    Biochem J; 1981 Mar; 193(3):907-13. PubMed ID: 7305965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of platelet-derived growth factor prepared from release products of fresh platelets and from outdated platelet concentrates.
    Chesterman CN; Walker T; Grego B; Chamberlain K; Hearn MT; Morgan FJ
    Biochem Biophys Res Commun; 1983 Nov; 116(3):809-16. PubMed ID: 6651847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib.
    Fujimura Y; Ikeda Y; Miura S; Yoshida E; Shima H; Nishida S; Suzuki M; Titani K; Taniuchi Y; Kawasaki T
    Thromb Haemost; 1995 Aug; 74(2):743-50. PubMed ID: 8585016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.
    George JN; Lyons RM; Morgan RK
    J Clin Invest; 1980 Jul; 66(1):1-9. PubMed ID: 6772667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Ouyang CH; Ma YH; Jih HC; Teng CM
    Biochim Biophys Acta; 1985 Jul; 841(1):1-7. PubMed ID: 4016143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V.
    Berndt MC; Phillips DR
    J Biol Chem; 1981 Jan; 256(1):59-65. PubMed ID: 6778867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human platelet aggregation by eosinophils.
    Maziero AM; Lorenzetti R; Donato JL; Lilla S; De Nucci G
    Life Sci; 2013 Sep; 93(9-11):416-22. PubMed ID: 23871985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.